Pregnancy Complications, Infectious
"Pregnancy Complications, Infectious" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION.
Descriptor ID |
D011251
|
MeSH Number(s) |
C01.539.674 C13.703.700
|
Concept/Terms |
Pregnancy Complications, Infectious- Pregnancy Complications, Infectious
- Infectious Pregnancy Complications
- Pregnancy, Infectious Complications
- Pregnancies, Infectious Complications
- Complications, Infectious Pregnancy
- Complication, Infectious Pregnancy
- Infectious Pregnancy Complication
- Pregnancy Complication, Infectious
|
Below are MeSH descriptors whose meaning is more general than "Pregnancy Complications, Infectious".
Below are MeSH descriptors whose meaning is more specific than "Pregnancy Complications, Infectious".
This graph shows the total number of publications written about "Pregnancy Complications, Infectious" by people in this website by year, and whether "Pregnancy Complications, Infectious" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1999 | 1 | 1 | 2 |
2000 | 1 | 2 | 3 |
2001 | 1 | 0 | 1 |
2002 | 2 | 1 | 3 |
2003 | 2 | 0 | 2 |
2004 | 6 | 0 | 6 |
2005 | 4 | 1 | 5 |
2006 | 3 | 5 | 8 |
2007 | 4 | 5 | 9 |
2008 | 1 | 2 | 3 |
2009 | 9 | 4 | 13 |
2010 | 4 | 3 | 7 |
2011 | 8 | 3 | 11 |
2012 | 10 | 3 | 13 |
2013 | 13 | 3 | 16 |
2014 | 15 | 0 | 15 |
2015 | 11 | 5 | 16 |
2016 | 10 | 8 | 18 |
2017 | 20 | 6 | 26 |
2018 | 14 | 3 | 17 |
2019 | 20 | 5 | 25 |
2020 | 19 | 4 | 23 |
2021 | 22 | 3 | 25 |
2022 | 9 | 1 | 10 |
2023 | 5 | 0 | 5 |
2024 | 6 | 7 | 13 |
2025 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pregnancy Complications, Infectious" by people in Profiles.
-
Longitudinal Changes in Tenofovir and Tenofovir Diphosphate Concentrations Among Pregnant Women Using Oral PrEP for HIV Prevention: Findings From Durban, South Africa. J Acquir Immune Defic Syndr. 2025 Apr 01; 98(4):357-362.
-
Prenatal SARS-CoV-2 Infection Alters Human Milk-Derived Extracellular Vesicles. Cells. 2025 02 15; 14(4).
-
Vaccine Utilization and Timing of Administration in Pregnant Women: A South African Perspective. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S85-S89.
-
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstet Gynecol. 2025 Feb 01; 145(2):157-167.
-
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan; 28(1):e26401.
-
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa. AIDS. 2025 Apr 01; 39(5):508-518.
-
Burden of Lassa fever disease in pregnant women and children and options for prevention. Vaccine. 2025 Jan 01; 43(Pt 1):126479.
-
Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial. J Acquir Immune Defic Syndr. 2024 Oct 01; 97(2):172-179.
-
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV. J Acquir Immune Defic Syndr. 2024 Oct; 97(2):150-155.
-
Cohort profile: Rahima Moosa Mother and Child Hospital maternal HIV cohort, Johannesburg, South Africa. BMJ Open. 2024 09 20; 14(9):e085082.